Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded May 15, 2026 · Filed May 16, 2026
The boss of Exponent sold $128K of Exponent shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$127,959
Shares × reported transaction price
15 days after results of Apr 30, 2026, 76 days before results of Jul 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.3% | +1.6% | −1.3% |
| 30 days | −0.6% | +0.3% | −0.9% |
| 90 days | +15.4% | +4.6% | +10.8% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.